kabutan

KAINOS Laboratories,Inc.(4556) Summary

4556
TSE Standard
KAINOS Laboratories,Inc.
2,280
JPY
0
(0.00%)
Mar 13, 3:30 pm JST
14.30
USD
Mar 13, 2:30 am EDT
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
16.0
PBR
1.35
Yield
ー%
Margin Trading Ratio
Stock Price
Mar 13, 2026
Opening Mar 13, 9:00 am
2,280 JPY 14.31 USD
Previous Close Mar 12
2,280 JPY 14.34 USD
High Mar 13, 9:14 am
2,282 JPY 14.34 USD
Low Mar 13, 9:00 am
2,280 JPY 14.29 USD
Volume
31,400
Trading Value
0.07B JPY 0.45M USD
VWAP
2280.16 JPY 14.31 USD
Minimum Trading Value
228,000 JPY 1,430 USD
Market Cap
0.01T JPY 0.07B USD
Number of Trades
42
Liquidity & Number of Trades
As of Mar 13, 2026
Liquidity
Slightly Low
1-Year Average
16
1-Year High Feb 12, 2026
202
Margin Trading
Date Short Interest Long Margin Positions Ratio
Mar 6, 2026 0 10,100
Feb 27, 2026 0 16,400
Feb 20, 2026 0 27,500
Feb 13, 2026 0 36,400
Feb 6, 2026 0 66,600
Company Profile
KAINOS Laboratories, Inc. is a mid-tier clinical diagnostics company specializing in renal function and allergy tests, with a focus on biochemistry and immunoserology.
Sector
Pharmaceuticals
KAINOS Laboratories, Inc. primarily engages in the manufacture and sale of in vitro diagnostic reagents and medical devices for clinical testing. The company operates independently without subsidiaries or affiliates, maintaining a continuous and close business relationship with Asahi Kasei Pharma. In the field of clinical diagnostics, KAINOS's main products include those for renal function and blood transfusion tests. The company particularly excels in biochemical and immunoserological testing, demonstrating its strengths in these areas. By providing essential products for diagnosis and treatment decisions in medical settings, KAINOS contributes to improving the quality of healthcare.